[{"id":"6f495b84-e66c-4014-bcbc-7265a6df59c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT04097002","created_at":"2021-07-05T17:25:16.739Z","updated_at":"2024-07-02T16:35:30.916Z","phase":"Phase 1/2","brief_title":"First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.","source_id_and_acronym":"NCT04097002","lead_sponsor":"Orca Therapeutics B.V.","biomarkers":" PCA3","pipe":"","alterations":" ","tags":["PCA3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ORCA-010"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 11/12/2019","start_date":" 11/12/2019","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-10-31"}]